<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>9412209</identifier>
<setSpec>0210-4806</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Flores Corral, N</dc:author>
<dc:author>Rioja Sanz, L A</dc:author>
<dc:author>Martínez Jabaloyas, J M</dc:author>
<dc:author>González Romojaro, V</dc:author>
<dc:author>Jiménez Cruz, J F</dc:author>
<dc:author>Leiva Galvis, O</dc:author>
<dc:author>Corral Saleta, J</dc:author>
<dc:author>Del Rosal Samaniego, J M</dc:author>
<dc:author>Lledó García, E</dc:author>
<dc:author>Resel Estévez, L</dc:author>
<dc:author>Sanz Chinesta, S</dc:author>
<dc:author>Unda Urzaiz, M</dc:author>
<dc:author>Hernández Fernández, C</dc:author>
<dc:author>Burgos Rodríguez, R</dc:author>
<dc:author>Camacho González, J E</dc:author>
<dc:author>Ruíz Alvárez-Cienfuegos, F</dc:author>
<dc:author>Gonzalvo Ibarra, A</dc:author>
<dc:description xml:lang="en">Prospective, randomized, multicenter study in 267 patients with complicated urinary infection from 9 hospitals nationwide. Drug treatment was either Ceftriaxone 1 g once daily parenterally or Cefotaxime parenteral 1 g 8 hourly for a minimum of 7 days. Patients were clinically, analytically and microbiologically evaluated before and after treatment to assess the efficacy and tolerance of both drug products. To evaluate treatment cost, we used the price of both drugs and the material required for their administration (syringe and disposable needle). 119 patients were excluded from the cost-efficacy evaluation and 148 remained in the study (75 assigned to treatment with Ceftriaxone and 73 to Cefotaxime). Clinical efficacy of treatment was 93% and 87.6% for Ceftriaxone and Cefotaxime respectively (p &gt; 0.05). Cost per patient was 27,347 pesetas for Ceftriaxone and 34,490 for Cefotaxime (p &lt; 0.05).</dc:description>
<dc:type>Clinical Trial</dc:type>
<dc:language>es</dc:language>
<dc:date>1997 Jul-Aug </dc:date>
<dc:title xml:lang="es">Estudio comparativo coste eficacia ceftriaxona versus cefotaxima en el tratamiento de las infecciones urinarias complicadas.</dc:title>
<dc:title xml:lang="en">[Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].</dc:title>
<dc:publisher>Actas urologicas espanolas</dc:publisher>
</metadata>
</record>
</pubmed-document>
